BioCentury
ARTICLE | Distillery Therapeutics

Cancer

June 6, 2018 7:06 PM UTC

Cell culture and mouse studies suggest inhibiting PHIP could help treat triple-negative breast cancer (TNBC) and NSCLC. In two human TNBC cell lines, shRNA targeting PHIP decreased colony formation co...